China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Longitudinal study of changes in symptoms during treatment with tiutumumab in patients with thyroid eye disease'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129479
Registration Time: 2026/08/05
Type: Observational study
Primary Sponsor: West China Hospital of Sichuan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332409
Published by HT Digital Content Services with permission from Health Daily Digest....